Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 — PRINCIPLE Trial

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.
— Read on www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19/

‘This is such a serious disease’: Inside an ICU patient transfer as COVID-19 cases rise | CTV News

While patients get sicker and ICUs continue to fill up, critical care physicians are transporting patients between hospitals to free up beds in some of Ontario’s hardest hit regions.
— Read on www.ctvnews.ca/health/coronavirus/this-is-such-a-serious-disease-inside-an-icu-patient-transfer-as-covid-19-cases-rise-1.5381715